{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:00:22Z","timestamp":1790762422572,"version":"4.1.0"},"reference-count":48,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/ijo.2015.3066","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T07:07:23Z","timestamp":1435561643000},"page":"971-980","source":"Crossref","is-referenced-by-count":23,"title":["Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells"],"prefix":"10.3892","volume":"47","author":[{"given":"JAN","family":"HRABETA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMAS","family":"GROH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MOHAMED ASHRAF","family":"KHALIL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JITKA","family":"POLJAKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VOJTECH","family":"ADAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RENE","family":"KIZEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIRI","family":"UHLIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HELENA","family":"DOKTOROVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TEREZA","family":"CERNA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EVA","family":"FREI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIE","family":"STIBOROVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMAS","family":"ECKSCHLAGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"key20180107190555_b1-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: Biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107190555_b2-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(03)01166-5","article-title":"Neuroblastoma: Biology and molecular and chromosomal pathology","volume":"4","author":"Schwab","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20180107190555_b3-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1651-2227.2004.tb03063.x","article-title":"Wilms' tumor and neuroblastoma","volume":"93","author":"Morgenstern","year":"2004","journal-title":"Acta Paediatr (Suppl)"},{"key":"key20180107190555_b4-ijo-47-03-0971","first-page":"1029","article-title":"Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression","volume":"27","author":"Kotchetkov","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180107190555_b5-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1476-4598-8-80","article-title":"Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells","volume":"8","author":"Michaelis","year":"2009","journal-title":"Mol Cancer"},{"key":"key20180107190555_b6-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbapap.2010.05.016","article-title":"Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency","volume":"1814","author":"Stiborov\u00e1","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180107190555_b7-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/09298673113206660272","article-title":"Ellipticines as DNA-targeted chemo-therapeutics","volume":"21","author":"Stiborov\u00e1","year":"2014","journal-title":"Curr Med Chem"},{"key":"key20180107190555_b8-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.bcp.2009.01.021","article-title":"The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells","volume":"77","author":"Poljakov\u00e1","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 1","key":"key20180107190555_b9-ijo-47-03-0971","first-page":"101","article-title":"Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma","volume":"32","author":"Poljakova","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"key20180107190555_b10-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.2174\/092986712802884286","article-title":"The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment","volume":"19","author":"Stiborov\u00e1","year":"2012","journal-title":"Curr Med Chem"},{"key":"key20180107190555_b11-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/S1452-3981(23)08197-X","article-title":"Expression levels of enzymes metabolizing an anticancer drug ellipticine determined by electromigration assays influence its cytotoxicity to cancer cells - a comparative study","volume":"9","author":"Stiborova","year":"2014","journal-title":"Int J Electrochem Sci"},{"key":"key20180107190555_b12-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0006-2952(01)00806-1","article-title":"The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts","volume":"62","author":"Stiborov\u00e1","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"key20180107190555_b13-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1158\/0008-5472.CAN-04-2202","article-title":"The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide","volume":"64","author":"Stiborov\u00e1","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107190555_b14-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5507\/bp.2006.002","article-title":"Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine","volume":"150","author":"Stiborova","year":"2006","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"key20180107190555_b15-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.22247","article-title":"Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine","volume":"120","author":"Stiborov\u00e1","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180107190555_b16-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2011.07.006","article-title":"Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances","volume":"133","author":"Kizek","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key20180107190555_b17-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1349-7006.2011.02137.x","article-title":"Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells","volume":"103","author":"Proch\u00e1zka","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180107190555_b18-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbabio.2014.01.018","article-title":"Eukaryotic V-ATPase: Novel structural findings and functional insights","volume":"1837","author":"Marshansky","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20180107190555_b19-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm1315","article-title":"Endocytic recycling","volume":"5","author":"Maxfield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107190555_b20-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","article-title":"Mechanisms of amine accumulation in, and egress from, lysosomes","volume":"1","author":"Goldman","year":"2009","journal-title":"Bioanalysis"},{"key":"key20180107190555_b21-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymgme.2011.12.012","article-title":"Mannose-6-phosphate pathway: A review on its role in lysosomal function and dysfunction","volume":"105","author":"Coutinho","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key20180107190555_b22-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1073\/pnas.91.3.1128","article-title":"Intracellular pH and the control of multidrug resistance","volume":"91","author":"Simon","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107190555_b23-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity, ion trapping and chemotherapeutics. I Acid pH affects the distribution of chemotherapeutic agents in vitro","volume":"66","author":"Mahoney","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"key20180107190555_b24-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2008.103","article-title":"Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration","volume":"22","author":"Chapuy","year":"2008","journal-title":"Leukemia"},{"key":"key20180107190555_b25-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-9966-29-44","article-title":"Proton pump inhibitors as anti vacuolar-ATPases drugs: A novel anticancer strategy","volume":"29","author":"Spugnini","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107190555_b26-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","article-title":"P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration","volume":"288","author":"Yamagishi","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180107190555_b27-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0006-2952(02)01072-9","article-title":"Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes","volume":"64","author":"Frei","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20180107190555_b28-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canlet.2006.12.037","article-title":"DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells","volume":"252","author":"Poljakov\u00e1","year":"2007","journal-title":"Cancer Lett"},{"issue":"Suppl 1","key":"key20180107190555_b29-ijo-47-03-0971","first-page":"60","article-title":"Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells","volume":"30","author":"Martinkova","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"key":"key20180107190555_b30-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ijc.25187","article-title":"alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells","volume":"127","author":"Martinkova","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107190555_b31-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.11511","article-title":"DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling","volume":"107","author":"Stiborov\u00e1","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107190555_b32-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tox.2007.03.026","article-title":"Formation and persistence of DNA adducts of anticancer drug ellipticine in rats","volume":"236","author":"Stiborov\u00e1","year":"2007","journal-title":"Toxicology"},{"key":"key20180107190555_b33-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.taap.2007.09.017","article-title":"Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse","volume":"226","author":"Stiborov\u00e1","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20180107190555_b34-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/bies.950180508","article-title":"Intracellular trafficking of lysosomal membrane proteins","volume":"18","author":"Hunziker","year":"1996","journal-title":"Bioessays"},{"key":"key20180107190555_b35-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00418-012-1057-6","article-title":"Interactions between autophagic and endo-lysosomal markers in endothelial cells","volume":"139","author":"Oeste","year":"2013","journal-title":"Histochem Cell Biol"},{"key":"key20180107190555_b36-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568011043482070","article-title":"Extending nature's leads: The anti-cancer agent ellipticine","volume":"4","author":"Garbett","year":"2004","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"key20180107190555_b37-ijo-47-03-0971","first-page":"3221","article-title":"Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo","volume":"7","author":"Wu","year":"2012","journal-title":"Int J Nanomed"},{"key":"key20180107190555_b38-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1073\/pnas.85.21.7972","article-title":"Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells","volume":"85","author":"Bowman","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107190555_b39-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1242\/jeb.024067","article-title":"Inhibitors of V-ATPases: Old and new players","volume":"212","author":"Huss","year":"2009","journal-title":"J Exp Biol"},{"key":"key20180107190555_b40-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/mol.105.018408","article-title":"Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons","volume":"69","author":"Shacka","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20180107190555_b41-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(99)00022-2","article-title":"pH and drug resistance. I Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines","volume":"57","author":"Mart\u00ednez-Zaguil\u00e1n","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"key20180107190555_b42-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ijc.1418","article-title":"Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance","volume":"93","author":"Murakami","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107190555_b43-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1746-1596-7-180","article-title":"ABCG2\/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells","volume":"7","author":"Huang","year":"2012","journal-title":"Diagn Pathol"},{"key":"key20180107190555_b44-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol Cell Biol"},{"key":"key20180107190555_b45-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj2960297","article-title":"Wortmannin is a potent phospha-tidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses","volume":"296","author":"Arcaro","year":"1993","journal-title":"Biochem J"},{"key":"key20180107190555_b46-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1432-1033.1997.0240a.x","article-title":"The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes","volume":"243","author":"Blommaart","year":"1997","journal-title":"Eur J Biochem"},{"key":"key20180107190555_b47-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and sutophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol Biol"},{"key":"key20180107190555_b48-ijo-47-03-0971","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Solomon","year":"2009","journal-title":"Eur J Pharmacol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3066\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:07:34Z","timestamp":1691788054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,29]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/ijo.2015.3066"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3066","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]}}}